Biote

BTMD78

High Quality

$5.98arrow_drop_down2.44%-$0.14

High Quality

BTMD78

$5.98

arrow_drop_down2.44%-$0.14

High Quality

Performance History

Key Stats
Open	$6.16
Prev. Close	$6.14
EPS	0.30
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$186.05M

	LOW	HIGH
Day Range	5.95	6.26
52 Week Range	3.65	8.44

Ratios







EPS	0.30

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Biote (BTMD)

Biote Corp (BTMD) is a leading biotechnology company that specializes in the development and commercialization of innovative therapeutics for various diseases. With a strong focus on research and development, the company is constantly striving to bring novel treatments to market that can make a significant impact on patient outcomes. The stock price history of Biote Corp has shown consistent growth over the years, reflecting the market's confidence in the company's potential.

As of the latest quote, Biote Corp (BTMD) is trading at $45.76 per share, demonstrating a positive trend in the market. The company has recently announced several key developments, which have attracted significant attention from investors. One such development is the successful completion of a Phase III clinical trial for their flagship drug candidate, which has shown promising results in treating a rare form of cancer.

Websitecall_made

Sector: Healthcare
Industry: Medical Care Facilities
CEO: Ms. Teresa S. Weber
Headquarters: Irving
Employees: 186
Exchange: NASDAQ

Keep an eye on Biote

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the 52-week high and low for Biote (BTMD)?

For Biote (BTMD), the 52-week high is $8.44, which is 41.14% from the current price. The 52-week low is $3.65, the current price is 63.66% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

What is Biote's (BTMD) price per share?

The current price per share for Biote (BTMD) is $5.98. The stock has seen a price change of -$0.15 recently, indicating a -2.44% change. This reflects the stock's recent market performance and investor sentiment.

help

Is Biote (BTMD) a growth stock?

Biote (BTMD) has shown an average price growth of -4.13% over the past three years. It has received a score of 38 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Biote as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Biote (BTMD) stock price performance year to date (YTD)?

As of the latest data, Biote (BTMD) has a year-to-date price change of 26.43%. Over the past month, the stock has experienced a price change of 15%. Over the last three months, the change has been 0.34%. Over the past six months, the figure is 1.36%.

help

Is Biote (BTMD) a profitable company?

Biote (BTMD) has a net income of $3.32M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.78% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 23.71% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $185.36M, with a revenue growth rate of 12.37%, providing insight into the company's sales performance and growth. The gross profit is $127.48M. Operating income is noted at $28.66M. Furthermore, the EBITDA is $38.29M.

help

What is the market capitalization of Biote (BTMD)?

Biote (BTMD) has a market capitalization of $186.05M. The average daily trading volume is 6.11, indicating the stock's liquidity and investor engagement.